30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

PTC Therapeutics Inc (PTCT)

Track

Over the last 90 days, PTC Therapeutics Inc. has seen significant insider selling, with a net value of -$1,175,610.75. Executives have been net sellers, contributing to a negative net insider count. Notable recent transactions include proposed and planned sales by officers and senior executives, totaling millions in value, with no reported insider purchases.
Stock chart
Ticker: PTCT Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Almstead Neil Gregory
Officer
1 sale — total 100,000 USD
Proposed sale 24 Jun 2026
Value US$2,874,709.85 | Price 125.81 | Shares 77,838
Planned sale 22 Jun 2026
Value US$2,103,071.70 | Price 157.37 | Shares 96,939
Planned sale 22 Jun 2026
Value US$3,115,414.37 | Price 498.49 | Shares 40,811
Proposed sale 22 Jun 2026
Value US$100,000.00 | Price 80.91 | Shares 1,000
Proposed sale 22 Jun 2026
Value US$100,000.00 | Price 80.91 | Shares 1,000
Planned sale 17 Jun 2026
Value US$100,000.00 | Price 75.56 | Shares 1,000
Planned sale 17 Jun 2026
Value US$100,000.00 | Price 75.56 | Shares 1,000
Proposed sale 17 Jun 2026
Value US$100,000.00 | Price 75.56 | Shares 1,000
Planned sale 17 Jun 2026
Value US$100,000.00 | Price 79.25 | Shares 1,000
Planned sale 17 Jun 2026
Value US$100,000.00 | Price 79.25 | Shares 1,000
Planned sale 17 Jun 2026
Value US$100,000.00 | Price 78.50 | Shares 1,000
Planned sale 17 Jun 2026
Value US$100,000.00 | Price 78.50 | Shares 1,000
Planned sale 17 Jun 2026
Value US$100,000.00 | Price 79.24 | Shares 1,000
Planned sale 17 Jun 2026
Value US$100,000.00 | Price 79.24 | Shares 1,000
Planned sale 17 Jun 2026
Value US$100,000.00 | Price 78.50 | Shares 1,000
Planned sale 17 Jun 2026
Value US$100,000.00 | Price 78.50 | Shares 1,000
Proposed sale 17 Jun 2026
Value US$100,000.00 | Price 78.65 | Shares 1,000
Planned sale 10 Jun 2026
Value US$100,000.00 | Price 75.00 | Shares 1,000
Planned sale 10 Jun 2026
Value US$100,000.00 | Price 75.00 | Shares 1,000
Proposed sale 10 Jun 2026
Value US$100,000.00 | Price 75.00 | Shares 1,000
Planned sale 15 May 2026
Value US$33,137.52 | Price 72.67 | Shares 456
Planned sale 15 May 2026
Value US$169,820.48 | Price 72.08 | Shares 2,356
Proposed sale 15 May 2026
Value US$203,729.40 | Price 72.45 | Shares 2,812
Sale 14 May 2026
Value US$186,367.12 | Price 72.46 | Shares 2,572
Sale 14 May 2026
Value US$153,468.00 | Price 73.08 | Shares 2,100
Sale 14 May 2026
Value US$527,710.68 | Price 73.08 | Shares 7,221
Sale 14 May 2026
Value US$49,607.74 | Price 73.06 | Shares 679
Proposed sale 14 May 2026
Value US$186,360.43 | Price 72.46 | Shares 2,572
Proposed sale 14 May 2026
Value US$730,769.00 | Price 73.08 | Shares 10,000
Planned sale 8 May 2026
Value US$47,568.00 | Price 79.28 | Shares 600
Planned sale 8 May 2026
Value US$15,600.00 | Price 78.00 | Shares 200
Planned sale 8 May 2026
Value US$150,689.00 | Price 79.31 | Shares 1,900
Planned sale 8 May 2026
Value US$65,713.20 | Price 78.23 | Shares 840
Proposed sale 8 May 2026
Value US$279,565.00 | Price 78.97 | Shares 3,540
Sale 21 Apr 2026
Value US$202,093.50 | Price 70.91 | Shares 2,850
Proposed sale 21 Apr 2026
Value US$202,171.31 | Price 70.94 | Shares 2,850
Planned sale 6 Apr 2026
Value US$100,649.25 | Price 69.75 | Shares 1,443
Planned sale 6 Apr 2026
Value US$56,644.02 | Price 68.91 | Shares 822
Proposed sale 6 Apr 2026
Value US$157,282.93 | Price 69.44 | Shares 2,265
Sale 2 Apr 2026
Value US$56,363.71 | Price 67.99 | Shares 829
Proposed sale 2 Apr 2026
Value US$56,366.11 | Price 67.99 | Shares 829
Planned sale 1 Apr 2026
Value US$5,624.00 | Price 70.30 | Shares 80
Planned sale 1 Apr 2026
Value US$870,835.00 | Price 69.50 | Shares 12,530
Planned sale 1 Apr 2026
Value US$2,713,783.77 | Price 68.89 | Shares 39,393
Proposed sale 1 Apr 2026
Value US$3,590,359.84 | Price 69.04 | Shares 52,003
Sale 12 Mar 2026
Value US$170,580.96 | Price 64.08 | Shares 2,662
Proposed sale 12 Mar 2026
Value US$170,572.44 | Price 64.08 | Shares 2,662
Planned sale 10 Mar 2026
Value US$980,000.00 | Price 70.00 | Shares 14,000
Planned sale 10 Mar 2026
Value US$81,690.00 | Price 70.00 | Shares 1,167
Proposed sale 10 Mar 2026
Value US$1,061,690.00 | Price 70.00 | Shares 15,167
Planned sale 5 Mar 2026
Value US$401,385.54 | Price 63.38 | Shares 6,333
Proposed sale 5 Mar 2026
Value US$401,385.54 | Price 63.38 | Shares 6,333
Planned sale 5 Mar 2026
Value US$633,800.00 | Price 63.38 | Shares 10,000
Proposed sale 5 Mar 2026
Value US$633,800.00 | Price 63.38 | Shares 10,000
Planned sale 5 Mar 2026
Value US$252,822.82 | Price 63.38 | Shares 3,989
Proposed sale 5 Mar 2026
Value US$252,822.82 | Price 63.38 | Shares 3,989
Planned sale 19 Feb 2026
Value US$41,193.80 | Price 69.82 | Shares 590
Planned sale 19 Feb 2026
Value US$14,530.48 | Price 68.54 | Shares 212
Planned sale 19 Feb 2026
Value US$113,736.78 | Price 69.82 | Shares 1,629
Planned sale 19 Feb 2026
Value US$40,301.52 | Price 68.54 | Shares 588
Proposed sale 19 Feb 2026
Value US$207,012.83 | Price 68.57 | Shares 3,019
Sale 18 Feb 2026
Value US$207,525.12 | Price 69.36 | Shares 2,992
Proposed sale 18 Feb 2026
Value US$207,514.95 | Price 69.36 | Shares 2,992
Sale 18 Feb 2026
Value US$172,290.24 | Price 69.36 | Shares 2,484
Sale 18 Feb 2026
Value US$172,983.84 | Price 69.36 | Shares 2,494
Proposed sale 18 Feb 2026
Value US$172,975.37 | Price 69.36 | Shares 2,494
Sale 18 Feb 2026
Value US$209,397.84 | Price 69.36 | Shares 3,019
Proposed sale 18 Feb 2026
Value US$209,387.58 | Price 69.36 | Shares 3,019
Sale 18 Feb 2026
Value US$4,508.40 | Price 69.36 | Shares 65
Sale 18 Feb 2026
Value US$211,964.16 | Price 69.36 | Shares 3,056
Proposed sale 18 Feb 2026
Value US$211,953.77 | Price 69.36 | Shares 3,056
Sale 18 Feb 2026
Value US$511,252.56 | Price 69.36 | Shares 7,371
Sale 18 Feb 2026
Value US$213,698.16 | Price 69.36 | Shares 3,081
Proposed sale 18 Feb 2026
Value US$213,687.69 | Price 69.36 | Shares 3,081
Proposed sale 18 Feb 2026
Value US$4,508.18 | Price 69.36 | Shares 65
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-24 2026-06-24 PrS Proposed sale
3.4
Almstead Neil Gregory

Officer

Officer
77,838
125.81
US$2,874,710 		77,838 125.81 US$2,874,710
2026-06-24 2026-06-22 PlS Planned sale
3.4
Almstead Neil Gregory

CHIEF TECHNICAL OPS OFFICER

Officer
96,939 +9.4%
157.37
US$2,103,072 		96,939 +9.4% 157.37 US$2,103,072
2026-06-24 2026-06-22 PlS Planned sale
3.4
Almstead Neil Gregory

CHIEF TECHNICAL OPS OFFICER

Officer
40,811 +31.0%
498.49
US$3,115,414 		40,811 +31.0% 498.49 US$3,115,414
2026-06-22 2026-06-22 PrS Proposed sale
3.4
Almstead Neil Gregory

Officer

Officer
1,000
80.91
US$100,000 		1,000 80.91 US$100,000
2026-06-22 2026-06-22 PrS Proposed sale
3.4
Almstead Neil Gregory

Officer

Officer
1,000
80.91
US$100,000 		1,000 80.91 US$100,000
2026-06-22 2026-06-17 PlS Planned sale
3.4
Utter Christine Marie

SVP, CHIEF ACCOUNTING OFFICER

Officer
1,000 -21.9%
75.56
US$100,000 		1,000 -21.9% 75.56 US$100,000
2026-06-22 2026-06-17 PlS Planned sale
3.4
Utter Christine Marie

SVP, CHIEF ACCOUNTING OFFICER

Officer
1,000 -21.9%
75.56
US$100,000 		1,000 -21.9% 75.56 US$100,000
2026-06-22 2026-06-17 PlS Planned sale
3.5
Boulding Mark Elliott

EXEC. VP AND CLO

Officer
1,000 -0.3%
79.25
US$100,000 		1,000 -0.3% 79.25 US$100,000
2026-06-22 2026-06-17 PlS Planned sale
3.5
Boulding Mark Elliott

EXEC. VP AND CLO

Officer
1,000 -0.3%
79.25
US$100,000 		1,000 -0.3% 79.25 US$100,000
2026-06-22 2026-06-17 PlS Planned sale
3.5
Boulding Mark Elliott

EXEC. VP AND CLO

Officer
1,000 -1.6%
78.50
US$100,000 		1,000 -1.6% 78.50 US$100,000
2026-06-22 2026-06-17 PlS Planned sale
3.5
Boulding Mark Elliott

EXEC. VP AND CLO

Officer
1,000 -1.6%
78.50
US$100,000 		1,000 -1.6% 78.50 US$100,000
2026-06-22 2026-06-17 PlS Planned sale
3.5
Boulding Mark Elliott

EXEC. VP AND CLO

Officer
1,000 -1.7%
79.24
US$100,000 		1,000 -1.7% 79.24 US$100,000
2026-06-22 2026-06-17 PlS Planned sale
3.5
Boulding Mark Elliott

EXEC. VP AND CLO

Officer
1,000 -1.7%
79.24
US$100,000 		1,000 -1.7% 79.24 US$100,000
2026-06-22 2026-06-17 PlS Planned sale
3.5
Boulding Mark Elliott

EXEC. VP AND CLO

Officer
1,000 -5.8%
78.50
US$100,000 		1,000 -5.8% 78.50 US$100,000
2026-06-22 2026-06-17 PlS Planned sale
3.5
Boulding Mark Elliott

EXEC. VP AND CLO

Officer
1,000 -5.8%
78.50
US$100,000 		1,000 -5.8% 78.50 US$100,000
2026-06-17 2026-06-17 PrS Proposed sale
3.5
Boulding Mark Elliott

Officer

Officer
1,000
78.65
US$100,000 		1,000 78.65 US$100,000
2026-06-17 2026-06-17 PrS Proposed sale
3.4
Utter Christine Marie

Officer

Officer
1,000
75.56
US$100,000 		1,000 75.56 US$100,000
2026-06-12 2026-06-10 PlS Planned sale
3.5
Pauwels Eric

CHIEF BUSINESS OFFICER

Officer
1,000 -19.3%
75.00
US$100,000 		1,000 -19.3% 75.00 US$100,000
2026-06-12 2026-06-10 PlS Planned sale
3.5
Pauwels Eric

CHIEF BUSINESS OFFICER

Officer
1,000 -4.8%
75.00
US$100,000 		1,000 -4.8% 75.00 US$100,000
2026-06-10 2026-06-10 PrS Proposed sale
3.5
Pauwels Eric

Officer

Officer
1,000
75.00
US$100,000 		1,000 75.00 US$100,000
2026-05-19 2026-05-15 PlS Planned sale
3.5
Boulding Mark Elliott

EXEC. VP AND CLO

Officer
456 -0.4%
72.67
US$33,138 		456 -0.4% 72.67 US$33,138
2026-05-19 2026-05-15 PlS Planned sale
3.5
Boulding Mark Elliott

EXEC. VP AND CLO

Officer
2,356 -2.2%
72.08
US$169,820 		2,356 -2.2% 72.08 US$169,820
2026-05-15 2026-05-15 PrS Proposed sale
3.5
Boulding Mark Elliott

Officer

Officer
2,812
72.45
US$203,729 		2,812 72.45 US$203,729
2026-05-15 2026-05-14 S Sale
3.1
Klein Matthew B.

CHIEF EXECUTIVE OFFICER

Executive Director
2,572 -0.6%
72.46
US$186,367 		2,572 -0.6% 72.46 US$186,367
2026-05-15 2026-05-14 S Sale
3.1
Klein Matthew B.

CHIEF EXECUTIVE OFFICER

Executive Director
2,100 -0.5%
73.08
US$153,468 		2,100 -0.5% 73.08 US$153,468
2026-05-15 2026-05-14 S Sale
3.1
Klein Matthew B.

CHIEF EXECUTIVE OFFICER

Executive Director
7,221 -1.8%
73.08
US$527,711 		7,221 -1.8% 73.08 US$527,711
2026-05-15 2026-05-14 S Sale
3.1
Klein Matthew B.

CHIEF EXECUTIVE OFFICER

Executive Director
679 -0.2%
73.06
US$49,608 		679 -0.2% 73.06 US$49,608
2026-05-14 2026-05-14 PrS Proposed sale
3.1
Klein Matthew B.

Officer; Director

Executive Director
2,572
72.46
US$186,360 		2,572 72.46 US$186,360
2026-05-14 2026-05-14 PrS Proposed sale
3.1
Klein Matthew B.

Officer; Director

Executive Director
10,000
73.08
US$730,769 		10,000 73.08 US$730,769
2026-05-12 2026-05-08 PlS Planned sale
3.5
Boulding Mark Elliott

EXEC. VP AND CLO

Officer
600 -0.6%
79.28
US$47,568 		600 -0.6% 79.28 US$47,568
2026-05-12 2026-05-08 PlS Planned sale
3.5
Boulding Mark Elliott

EXEC. VP AND CLO

Officer
200 -0.2%
78.00
US$15,600 		200 -0.2% 78.00 US$15,600
2026-05-12 2026-05-08 PlS Planned sale
3.5
Boulding Mark Elliott

EXEC. VP AND CLO

Officer
1,900 -1.8%
79.31
US$150,689 		1,900 -1.8% 79.31 US$150,689
2026-05-12 2026-05-08 PlS Planned sale
3.5
Boulding Mark Elliott

EXEC. VP AND CLO

Officer
840 -0.8%
78.23
US$65,713 		840 -0.8% 78.23 US$65,713
2026-05-08 2026-05-08 PrS Proposed sale
3.5
Boulding Mark Elliott

Officer

Officer
3,540
78.97
US$279,565 		3,540 78.97 US$279,565
2026-04-23 2026-04-21 S Sale
3.1
Klein Matthew B.

CHIEF EXECUTIVE OFFICER

Executive Director
2,850 -0.7%
70.91
US$202,094 		2,850 -0.7% 70.91 US$202,094
2026-04-21 2026-04-21 PrS Proposed sale
3.1
Klein Matthew B.

Officer; Director

Executive Director
2,850
70.94
US$202,171 		2,850 70.94 US$202,171
2026-04-08 2026-04-06 PlS Planned sale
3.5
Boulding Mark Elliott

EXEC. VP AND CLO

Officer
1,443 -1.4%
69.75
US$100,649 		1,443 -1.4% 69.75 US$100,649
2026-04-08 2026-04-06 PlS Planned sale
3.5
Boulding Mark Elliott

EXEC. VP AND CLO

Officer
822 -0.8%
68.91
US$56,644 		822 -0.8% 68.91 US$56,644
2026-04-06 2026-04-06 PrS Proposed sale
3.5
Boulding Mark Elliott

Officer

Officer
2,265
69.44
US$157,283 		2,265 69.44 US$157,283
2026-04-06 2026-04-02 S Sale
3.3
Golden Lee Scott

EVP & CHIEF MEDICAL OFFICER

Officer
829 -1.0%
67.99
US$56,364 		829 -1.0% 67.99 US$56,364
2026-04-02 2026-04-02 PrS Proposed sale
3.3
Golden Lee Scott

Officer

Officer
829
67.99
US$56,366 		829 67.99 US$56,366
2026-04-03 2026-04-01 PlS Planned sale
3.4
Almstead Neil Gregory

CHIEF TECHNICAL OPS OFFICER

Officer
80 -0.1%
70.30
US$5,624 		80 -0.1% 70.30 US$5,624
2026-04-03 2026-04-01 PlS Planned sale
3.4
Almstead Neil Gregory

CHIEF TECHNICAL OPS OFFICER

Officer
12,530 -17.2%
69.50
US$870,835 		12,530 -17.2% 69.50 US$870,835
2026-04-03 2026-04-01 PlS Planned sale
3.4
Almstead Neil Gregory

CHIEF TECHNICAL OPS OFFICER

Officer
39,393 -35.1%
68.89
US$2,713,784 		39,393 -35.1% 68.89 US$2,713,784
2026-04-01 2026-04-01 PrS Proposed sale
3.4
Almstead Neil Gregory

Officer

Officer
52,003
69.04
US$3,590,360 		52,003 69.04 US$3,590,360
2026-03-13 2026-03-12 S Sale
3.1
Klein Matthew B.

CHIEF EXECUTIVE OFFICER

Executive Director
2,662 -0.7%
64.08
US$170,581 		2,662 -0.7% 64.08 US$170,581
2026-03-12 2026-03-12 PrS Proposed sale
3.1
Klein Matthew B.

Officer; Director

Executive Director
2,662
64.08
US$170,572 		2,662 64.08 US$170,572
2026-03-12 2026-03-10 PlS Planned sale
3.4
Okey Stephanie
Non-Executive Director
14,000 -63.6%
70.00
US$980,000 		14,000 -63.6% 70.00 US$980,000
2026-03-12 2026-03-10 PlS Planned sale
3.4
Okey Stephanie
Non-Executive Director
1,167 -12.7%
70.00
US$81,690 		1,167 -12.7% 70.00 US$81,690
2026-03-10 2026-03-10 PrS Proposed sale
3.4
Okey Stephanie

Director

Non-Executive Director
15,167
70.00
US$1,061,690 		15,167 70.00 US$1,061,690
2026-03-09 2026-03-05 PlS Planned sale
3.4
Okey Stephanie
Non-Executive Director
6,333 -44.2%
63.38
US$401,386 		6,333 -44.2% 63.38 US$401,386
2026-03-09 2026-03-05 PlS Planned sale
3.3
Golden Lee Scott

EVP & CHIEF MEDICAL OFFICER

Officer
10,000 -11.1%
63.38
US$633,800 		10,000 -11.1% 63.38 US$633,800
2026-03-09 2026-03-05 PlS Planned sale
3.4
Almstead Neil Gregory

CHIEF TECHNICAL OPS OFFICER

Officer
3,989 -59.3%
63.38
US$252,823 		3,989 -59.3% 63.38 US$252,823
2026-03-05 2026-03-05 PrS Proposed sale
3.4
Okey Stephanie

Director

Non-Executive Director
6,333
63.38
US$401,386 		6,333 63.38 US$401,386
2026-03-05 2026-03-05 PrS Proposed sale
Almstead Zheng Yang

Member of immediate family of any of the foregoing
3,989
63.38
US$252,823 		3,989 63.38 US$252,823
2026-03-05 2026-03-05 PrS Proposed sale
3.3
Golden Lee Scott

Officer

Officer
10,000
63.38
US$633,800 		10,000 63.38 US$633,800
2026-02-23 2026-02-19 PlS Planned sale
3.5
Boulding Mark Elliott

EXEC. VP AND CLO

Officer
590 -0.6%
69.82
US$41,194 		590 -0.6% 69.82 US$41,194
2026-02-23 2026-02-19 PlS Planned sale
3.5
Boulding Mark Elliott

EXEC. VP AND CLO

Officer
212 -0.2%
68.54
US$14,530 		212 -0.2% 68.54 US$14,530
2026-02-23 2026-02-19 PlS Planned sale
3.5
Boulding Mark Elliott

EXEC. VP AND CLO

Officer
1,629 -1.5%
69.82
US$113,737 		1,629 -1.5% 69.82 US$113,737
2026-02-23 2026-02-19 PlS Planned sale
3.5
Boulding Mark Elliott

EXEC. VP AND CLO

Officer
588 -0.5%
68.54
US$40,302 		588 -0.5% 68.54 US$40,302
2026-02-19 2026-02-19 PrS Proposed sale
3.5
Boulding Mark Elliott

Officer

Officer
3,019
68.57
US$207,013 		3,019 68.57 US$207,013
2026-02-20 2026-02-18 S Sale
3.5
Gravier Pierre

CHIEF FINANCIAL OFFICER

Officer
2,992 -3.3%
69.36
US$207,525 		2,992 -3.3% 69.36 US$207,525
2026-02-20 2026-02-18 S Sale
3.3
Golden Lee Scott

EVP & CHIEF MEDICAL OFFICER

Officer
2,484 -2.7%
69.36
US$172,290 		2,484 -2.7% 69.36 US$172,290
2026-02-20 2026-02-18 S Sale
3.4
Utter Christine Marie

SVP, CHIEF ACCOUNTING OFFICER

Officer
2,494 -3.4%
69.36
US$172,984 		2,494 -3.4% 69.36 US$172,984
2026-02-20 2026-02-18 S Sale
3.5
Pauwels Eric

CHIEF BUSINESS OFFICER

Officer
3,019 -3.8%
69.36
US$209,398 		3,019 -3.8% 69.36 US$209,398
2026-02-20 2026-02-18 S Sale
3.4
Almstead Neil Gregory

CHIEF TECHNICAL OPS OFFICER

Officer
65 -1.0%
69.36
US$4,508 		65 -1.0% 69.36 US$4,508
2026-02-20 2026-02-18 S Sale
3.4
Almstead Neil Gregory

CHIEF TECHNICAL OPS OFFICER

Officer
3,056 -2.7%
69.36
US$211,964 		3,056 -2.7% 69.36 US$211,964
2026-02-20 2026-02-18 S Sale
3.1
Klein Matthew B.

CHIEF EXECUTIVE OFFICER

Executive Director
7,371 -1.9%
69.36
US$511,253 		7,371 -1.9% 69.36 US$511,253
2026-02-19 2026-02-18 S Sale
3.5
Boulding Mark Elliott

EXEC. VP AND CLO

Officer
3,081 -2.8%
69.36
US$213,698 		3,081 -2.8% 69.36 US$213,698
2026-02-18 2026-02-18 PrS Proposed sale
3.5
Pauwels Eric

Officer

Officer
3,019
69.36
US$209,388 		3,019 69.36 US$209,388
2026-02-18 2026-02-18 PrS Proposed sale
Almstead Zheng Yang

Member of immediate family of any of the foregoing
65
69.36
US$4,508 		65 69.36 US$4,508
2026-02-18 2026-02-18 PrS Proposed sale
3.5
Gravier Pierre

Officer

Officer
2,992
69.36
US$207,515 		2,992 69.36 US$207,515
2026-02-18 2026-02-18 PrS Proposed sale
3.4
Utter Christine Marie

Officer

Officer
2,494
69.36
US$172,975 		2,494 69.36 US$172,975
2026-02-18 2026-02-18 PrS Proposed sale
3.4
Almstead Neil Gregory

Officer

Officer
3,056
69.36
US$211,954 		3,056 69.36 US$211,954
2026-02-18 2026-02-18 PrS Proposed sale
3.5
Boulding Mark Elliott

Officer

Officer
3,081
69.36
US$213,688 		3,081 69.36 US$213,688
Explore more

More insider trading research around PTC Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America